HEALTH● LOWAug 29 · Aug 29, 2026, 4:45 AM
FDA Approves Takeda Mimrylo For Rare Blood Disorder Polycythemia Vera
finanzen.ch · Switzerland · north america
The FDA has approved Takeda Mimrylo for the treatment of polycythemia vera, a rare blood disorder. This represents a new medical option for patients with this condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapSwitzerland and nearby eventsMore from SwitzerlandLatest stories and threat level
More in Health
HEALTH19m agoKerala State Drugs Control dept. seeks curbs on inter-State drug procurement to ensure traceabilityThe HinduHEALTH34m ago93% of children affected by diphtheria outbreaks not fully vaccinated – OfficialPremium TimesHEALTH37m agoDr. Sandra G. Martín, dentist: "Health always comes before a pretty tooth. First biology and then aesthetics. The important thing is that everything is healthy."ClarínHEALTH1h agoMore workers are skipping doctor's visits over money worriesCBS News